Effects of DAPAgliflozin on CARDiac substrate uptake, myocardial efficiency, and myocardial contractile work in type 2 diabetes patients—a description of the DAPACARD study

Background: Diabetes increases the risk for cardiovascular (CV) events. It has recently been shown that the use of sodium-glucose cotransporter 2 (SGLT2) inhibitors leads to a reduction in CV outcomes in patients with type 2 diabetes mellitus (T2DM), including mortality and heart failure hospitaliza...

Full description

Bibliographic Details
Main Authors: Axel Åkerblom, Jonas Oldgren, Aino Latva-Rasku, Lars Johansson, Vera Lisovskaja, Cecilia Karlsson, Jan Oscarsson, Pirjo Nuutila
Format: Article
Language:English
Published: Upsala Medical Society 2019-01-01
Series:Upsala Journal of Medical Sciences
Subjects:
Online Access:http://dx.doi.org/10.1080/03009734.2018.1515281